Biodexa Pharmaceuticals PLC (BDRX) has initiated its first clinical site in the U.S. for a phase 3 trial of eRapa, an oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback